$ISIS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IONIS PHARMACEUTICALS INC. Get notifications about new insider transactions in IONIS PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | LOSCALZO JOSEPH | Director | Buy | M | 0.00 | 666 | 0 | 13,974 | 13.3 K to 14 K (+5.00 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 889 | 0 | 67,464 | 66.6 K to 67.5 K (+1.34 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 1,778 | 0 | 66,575 | 64.8 K to 66.6 K (+2.74 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 667 | 0 | 16,683 | 16 K to 16.7 K (+4.16 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 889 | 0 | 16,016 | 15.1 K to 16 K (+5.88 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 1,778 | 0 | 15,127 | 13.3 K to 15.1 K (+13.32 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 0.00 | 666 | 0 | 13,349 | 12.7 K to 13.3 K (+5.25 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 667 | 0 | 19,183 | 18.5 K to 19.2 K (+3.60 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 889 | 0 | 18,516 | 17.6 K to 18.5 K (+5.04 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 1,778 | 0 | 17,627 | 15.8 K to 17.6 K (+11.22 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 0.00 | 666 | 0 | 15,849 | 15.2 K to 15.8 K (+4.39 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | Reikes Peter N | Director | Buy | M | 0.00 | 1,778 | 0 | 3,556 | 1.8 K to 3.6 K (+100.00 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 667 | 0 | 65,805 | 65.1 K to 65.8 K (+1.02 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 889 | 0 | 65,138 | 64.2 K to 65.1 K (+1.38 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 1,778 | 0 | 64,249 | 62.5 K to 64.2 K (+2.85 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | WENDER JOSEPH H | Director | Buy | M | 0.00 | 666 | 0 | 62,471 | 61.8 K to 62.5 K (+1.08 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 667 | 0 | 100,983 | 100.3 K to 101 K (+0.66 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 889 | 0 | 100,316 | 99.4 K to 100.3 K (+0.89 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 1,778 | 0 | 99,427 | 97.6 K to 99.4 K (+1.82 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 0.00 | 666 | 0 | 97,649 | 97 K to 97.6 K (+0.69 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 60.20 | 12,000 | 722,400 | 12,000 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | A | 0.00 | 5,333 | 0 | 5,333 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 667 | 0 | 666 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 889 | 0 | 1,777 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 1,778 | 0 | 5,332 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 0.00 | 666 | 0 | 0 | |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 667 | 0 | 31,683 | 31 K to 31.7 K (+2.15 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 889 | 0 | 31,016 | 30.1 K to 31 K (+2.95 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 1,778 | 0 | 30,127 | 28.3 K to 30.1 K (+6.27 %) |
| Jul 06 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 0.00 | 666 | 0 | 28,349 | 27.7 K to 28.3 K (+2.41 %) |
| Jul 02 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Option Exercise | M | 9.22 | 15,000 | 138,300 | 0 | |
| Jul 02 2020 | ISIS | IONIS PHARMACEUTIC ... | MUTO FREDERICK T | Director | Buy | M | 9.22 | 15,000 | 138,300 | 27,683 | 12.7 K to 27.7 K (+118.27 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 26.66 | 10,000 | 266,600 | 12,500 | |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Sell | S | 60.00 | 10,000 | 600,000 | 15,183 | 25.2 K to 15.2 K (-39.71 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 26.66 | 10,000 | 266,600 | 25,183 | 15.2 K to 25.2 K (+65.86 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | EVP, Chief Scientif ... | Option Exercise | M | 39.87 | 15,000 | 598,050 | 30,000 | |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | EVP, Chief Scientif ... | Sell | S | 59.77 | 15,000 | 896,505 | 32,364 | 47.4 K to 32.4 K (-31.67 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | EVP, Chief Scientif ... | Buy | M | 39.87 | 15,000 | 598,050 | 47,364 | 32.4 K to 47.4 K (+46.35 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Option Exercise | M | 26.66 | 10,000 | 266,600 | 12,500 | |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Sell | S | 60.00 | 10,000 | 600,000 | 15,183 | 25.2 K to 15.2 K (-39.71 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | Castleman Breaux | Director | Buy | M | 26.66 | 10,000 | 266,600 | 25,183 | 15.2 K to 25.2 K (+65.86 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | EVP, Chief Scientif ... | Option Exercise | M | 39.87 | 15,000 | 598,050 | 30,000 | |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | EVP, Chief Scientif ... | Sell | S | 59.77 | 15,000 | 896,505 | 32,364 | 47.4 K to 32.4 K (-31.67 %) |
| Jun 29 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | EVP, Chief Scientif ... | Buy | M | 39.87 | 15,000 | 598,050 | 47,364 | 32.4 K to 47.4 K (+46.35 %) |
| Jun 26 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 60.11 | 9,914 | 595,907 | 2,021 | 11.9 K to 2 K (-83.07 %) |
| Jun 26 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 58.80 | 5,000 | 294,000 | 11,935 | 16.9 K to 11.9 K (-29.52 %) |
| Jun 25 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Option Exercise | M | 9.22 | 15,000 | 138,300 | 0 | |
| Jun 25 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Sell | S | 58.76 | 15,000 | 881,400 | 96,983 | 112 K to 97 K (-13.39 %) |
| Jun 25 2020 | ISIS | IONIS PHARMACEUTIC ... | BERTHELSEN SPENCER R | Director | Buy | M | 9.22 | 15,000 | 138,300 | 111,983 | 97 K to 112 K (+15.47 %) |
| Jun 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 58.33 | 10,000 | 583,250 | 16,935 | 26.9 K to 16.9 K (-37.13 %) |
| Jun 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 58.25 | 2,000 | 116,500 | 3,581 | 5.6 K to 3.6 K (-35.84 %) |
| Jun 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 57.90 | 15,000 | 868,521 | 26,935 | 41.9 K to 26.9 K (-35.77 %) |
| Jun 17 2020 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Option Exercise | M | 0.00 | 3,556 | 0 | 10,665 | |
| Jun 17 2020 | ISIS | IONIS PHARMACEUTIC ... | HERMAN JOAN E | Director | Buy | M | 0.00 | 3,556 | 0 | 3,556 | 0 to 3.6 K |
| Mar 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 45.00 | 1,000 | 45,000 | 6,581 | 7.6 K to 6.6 K (-13.19 %) |
| Mar 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 46.00 | 5,000 | 230,000 | 56,545 | 61.5 K to 56.5 K (-8.12 %) |
| Mar 23 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 44.75 | 10,000 | 447,546 | 61,545 | 71.5 K to 61.5 K (-13.98 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 45.00 | 4,349 | 195,705 | 71,545 | 75.9 K to 71.5 K (-5.73 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 45.00 | 5,651 | 254,295 | 75,894 | 81.5 K to 75.9 K (-6.93 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 44.50 | 5,421 | 241,235 | 81,545 | 87 K to 81.5 K (-6.23 %) |
| Mar 19 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Exec Chairman of th ... | Sell | S | 44.50 | 4,969 | 221,121 | 86,966 | 91.9 K to 87 K (-5.40 %) |
| Mar 03 2020 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | SVP, Research | Buy | J | 43.16 | 378 | 16,316 | 5,301 | 4.9 K to 5.3 K (+7.68 %) |
| Mar 03 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP & General Couns ... | Buy | J | 43.16 | 289 | 12,474 | 21,009 | 20.7 K to 21 K (+1.39 %) |
| Mar 03 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Buy | J | 43.16 | 314 | 13,553 | 28,957 | 28.6 K to 29 K (+1.10 %) |
| Mar 03 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | J | 43.16 | 147 | 6,345 | 32,374 | 32.2 K to 32.4 K (+0.46 %) |
| Mar 03 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | J | 43.16 | 378 | 16,316 | 30,446 | 30.1 K to 30.4 K (+1.26 %) |
| Mar 03 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | J | 43.16 | 169 | 7,295 | 32,364 | 32.2 K to 32.4 K (+0.52 %) |
| Feb 11 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP & General Couns ... | Sell | S | 59.60 | 3,882 | 231,367 | 20,720 | 24.6 K to 20.7 K (-15.78 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | SVP, Research | Option Exercise | M | 0.00 | 6,522 | 0 | 13,653 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | SVP, Research | Option Exercise | A | 0.00 | 12,235 | 0 | 12,235 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | SVP, Research | Payment of Exercise | F | 62.06 | 2,367 | 146,896 | 4,923 | 7.3 K to 4.9 K (-32.47 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | SVP, Research | Buy | M | 0.00 | 6,522 | 0 | 7,290 | 768 to 7.3 K (+849.22 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Option Exercise | M | 0.00 | 15,136 | 0 | 16,409 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Payment of Exercise | F | 62.06 | 3,905 | 242,344 | 64,797 | 68.7 K to 64.8 K (-5.68 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | PARSHALL B LYNNE | Director | Buy | M | 0.00 | 15,136 | 0 | 68,702 | 53.6 K to 68.7 K (+28.26 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 0.00 | 12,045 | 0 | 24,552 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | A | 0.00 | 24,205 | 0 | 24,205 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Payment of Exercise | F | 62.06 | 4,277 | 265,431 | 24,602 | 28.9 K to 24.6 K (-14.81 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 0.00 | 12,045 | 0 | 28,879 | 16.8 K to 28.9 K (+71.55 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | M | 0.00 | 19,921 | 0 | 46,087 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 0.00 | 17,009 | 0 | 17,009 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 0.00 | 65,979 | 0 | 65,979 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Payment of Exercise | F | 62.06 | 7,563 | 469,360 | 28,643 | 36.2 K to 28.6 K (-20.89 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Buy | M | 0.00 | 19,921 | 0 | 36,206 | 16.3 K to 36.2 K (+122.33 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 0.00 | 12,044 | 0 | 24,550 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | A | 0.00 | 26,800 | 0 | 26,800 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Payment of Exercise | F | 62.06 | 4,277 | 265,431 | 32,227 | 36.5 K to 32.2 K (-11.72 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 0.00 | 12,044 | 0 | 36,504 | 24.5 K to 36.5 K (+49.24 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | M | 0.00 | 13,139 | 0 | 27,639 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 0.00 | 24,205 | 0 | 24,205 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Payment of Exercise | F | 62.06 | 4,654 | 288,827 | 30,068 | 34.7 K to 30.1 K (-13.40 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Buy | M | 0.00 | 13,139 | 0 | 34,722 | 21.6 K to 34.7 K (+60.88 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | M | 0.00 | 3,317 | 0 | 6,627 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | M | 0.00 | 39,643 | 0 | 72,160 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 0.00 | 5,545 | 0 | 5,545 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 0.00 | 62,982 | 0 | 62,982 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Payment of Exercise | F | 62.06 | 1,268 | 78,692 | 7,581 | 8.8 K to 7.6 K (-14.33 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Buy | M | 0.00 | 3,317 | 0 | 8,849 | 5.5 K to 8.8 K (+59.96 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Payment of Exercise | F | 62.06 | 17,342 | 1,076,245 | 91,935 | 109.3 K to 91.9 K (-15.87 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Buy | M | 0.00 | 39,643 | 0 | 109,277 | 69.6 K to 109.3 K (+56.93 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Dev and ... | Option Exercise | A | 0.00 | 22,667 | 0 | 22,667 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | M | 0.00 | 11,711 | 0 | 23,549 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | A | 0.00 | 21,612 | 0 | 21,612 | |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Payment of Exercise | F | 62.06 | 4,162 | 258,294 | 32,195 | 36.4 K to 32.2 K (-11.45 %) |
| Jan 17 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Buy | M | 0.00 | 11,711 | 0 | 36,357 | 24.6 K to 36.4 K (+47.52 %) |
| Jan 13 2020 | ISIS | IONIS PHARMACEUTIC ... | Cadoret-Manier Onaiza | Chief Corp Developm ... | Option Exercise | A | 63.27 | 51,000 | 3,226,770 | 51,000 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | Swayze Eric | SVP, Research | Option Exercise | A | 60.89 | 27,528 | 1,676,180 | 27,528 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | A | 60.89 | 54,461 | 3,316,130 | 54,461 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Option Exercise | A | 60.89 | 158,659 | 9,660,747 | 158,659 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | Monia Brett P | Chief Executive Off ... | Sell | S | 60.25 | 173 | 10,423 | 16,285 | 16.5 K to 16.3 K (-1.05 %) |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | A | 60.89 | 60,299 | 3,671,606 | 60,299 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | Geary Richard S | SVP, Development | Option Exercise | A | 60.89 | 54,461 | 3,316,130 | 54,461 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 60.89 | 12,477 | 759,725 | 12,477 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Executive Chairman ... | Option Exercise | A | 60.89 | 141,709 | 8,628,661 | 141,709 | |
| Jan 03 2020 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | Chief Scientific Of ... | Option Exercise | A | 60.89 | 48,626 | 2,960,837 | 48,626 | |
| Dec 23 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Option Exercise | M | 35.53 | 1,000 | 35,530 | 0 | |
| Dec 23 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Sell | S | 61.87 | 1,000 | 61,874 | 12,683 | 13.7 K to 12.7 K (-7.31 %) |
| Dec 23 2019 | ISIS | IONIS PHARMACEUTIC ... | KLEIN JOSEPH III | Director | Buy | M | 35.53 | 1,000 | 35,530 | 13,683 | 12.7 K to 13.7 K (+7.88 %) |
| Dec 20 2019 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 10.82 | 3,438 | 37,199 | 0 |